<DOC>
	<DOCNO>NCT00610142</DOCNO>
	<brief_summary>explore atrophogenic potential hydrocortison 1 % cream pimecrolimus 1 % cream unaffected forehead skin</brief_summary>
	<brief_title>Comparison Atrophogenic Effect Hydrocortison 1 % Cream Pimecrolimus 1 % Cream Assessed Optical Coherence Tomography ( OCT ) 20-MHz Ultrasound Uninvolved Skin Patients With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Cortisone</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>age 1860 year diagnosis atopic dermatitis ( Hanifin &amp; Rajka Criteria ) patient atopic dermatitis affect forehead pregnancy / nursing mother woman reproductive age without adequate contraception severe atopic dermatitis ( IGA &gt; = 4 ) UVTherapy past 4 week patient receive topical treatment face past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>pimecrolimus</keyword>
	<keyword>hydrocortison</keyword>
	<keyword>Optical Coherence Tomography</keyword>
</DOC>